ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,427.13
      -2.31%
      US Tech 100
      18,601.20
      -3.24%
      Dow Jones
      39,853.87
      -1.25%
      Brent Oil
      80.425
      -0.38%
      Bitcoin
      64,234.55
      -1.75%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Iterum Therapeutics PLC (ITRM)

      7. Iterum Therapeutics PLC (ITRM) Financials

      Iterum Therapeutics PLC

      Iterum Therapeutics PLC (ITRM)

      NASDAQ
      1.255
      -0.035
      (-2.71%)
      Closed July 24 4:00PM
      Delayed by 15 minutes
      1.255
      0.00
      (0.00%)
      After Hours: 5:09PM
      Delayed by 15 minutes

      Iterum Therapeutics PLC Financial Summary

      The current ITRM market cap is 20.78M. The company's latest EPS is USD -2.3178 and P/E is -0.54.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 41k50k70k-79k0
      Operating Income -8.49M-10.77M-16.62M-11.51M-6.16M
      Net Income -9.89M-12.24M-3.88M-12.36M-7.1M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 233k553k195k503k82k
      Operating Income -101.83M-31.57M-24.34M-29.12M-47.39M
      Net Income -103.13M-52.01M-91.56M-43.67M-38.37M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 58.12M51.02M39.73M26.26M19.63M
      Total Liabilities 39.16M43.89M36.3M32.66M25.78M
      Total Equity 18.96M7.13M3.43M-6.4M-6.15M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 25.75M32.79M91.51M66.83M26.26M
      Total Liabilities 51.99M83.35M41.28M38.83M32.66M
      Total Equity -26.24M-50.56M50.23M28M-6.4M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.59M-17.22M-26.49M-39.33M-13.08M
      Investing 5.11M9.45M9.81M23.34M7.21M
      Financing 235k435k445k1.03M7.22M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -78.89M-54.53M-15.84M-18.47M-39.33M
      Investing 40.1M-11k-54.6M13.96M23.34M
      Financing -974k64.48M83.13M-1.82M1.03M

      Stats and Ratios

      Market Cap 20.78M
      Price to Earnings Ratio -0.54
      Price to Sales Ratio 250
      Price to Cash Ratio 3.41
      Price to Book Ratio -3.23
      Dividend Yield -

      Share Statistics

      Shares Outstanding 16.55M
      Average Volume (1 week) 199.29k
      Average Volume (1 Month) 281.12k
      52 Week Change 13.06%
      52 Week High 2.64
      52 Week Low 0.622
      Spread (Intraday) 0.05 (4%)

      Company Info

      Company Name Iterum Therapeutics PLC
      Address 200 s wacker drive
      chicago, illinois IL 60606
      Website https://www.iterumtx.com
      Industry pharmaceutical preparations (2834)